Caricamento...
Antisense oligonucleotides: A primer
There are few disease-modifying therapeutics for neurodegenerative diseases, but successes on the development of antisense oligonucleotide (ASO) therapeutics for spinal muscular atrophy and Duchenne muscular dystrophy predict a robust future for ASOs in medicine. Indeed, existing pipelines for the d...
Salvato in:
| Pubblicato in: | Neurol Genet |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Wolters Kluwer
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6501637/ https://ncbi.nlm.nih.gov/pubmed/31119194 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXG.0000000000000323 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|